A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
Clinical trial NCT01668966 · COMPLETED
Trial details
- NCT number
- NCT01668966
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-09
- Primary completion
- 2016-05-11
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.